Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionToth Financial Advisory Corp
Latest Disclosed Ownership27,113 shares
Latest Disclosed Value $ 9,539,882
Toth Financial Advisory Corp reports 1.56% increase in ownership of AMGN / Amgen Inc.

On April 16, 2026 - Toth Financial Advisory Corp filed a 13F-HR form disclosing ownership of 27,113 shares of Amgen Inc. (MX:AMGN) valued at $9,539,882 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 26,697 shares of Amgen Inc.. This represents a change in shares of 1.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F AMGEN COM 031162100 27,113 416 1.56 9,540 9.17 1.0472
2026-01-20 2025-12-31 13F AMGEN COM 031162100 26,697 1,009 3.93 8,738 20.54 0.9489
2025-10-09 2025-09-30 13F AMGEN COM 031162100 25,688 1 0.00 7,249 1.07 0.7816
2025-07-14 2025-06-30 13F AMGEN COM 031162100 25,687 507 2.01 7,172 -8.57 0.8367
2025-04-14 2025-03-31 13F AMGEN COM 031162100 25,180 -382 -1.49 7,845 17.74 0.9444
2025-01-21 2024-12-31 13F AMGEN COM 031162100 25,562 -557 -2.13 6,662 -20.83 0.7836
2024-10-21 2024-09-30 13F AMGEN COM 031162100 26,119 -923 -3.41 8,416 -0.40 0.9937
2024-07-16 2024-06-30 13F AMGEN COM 031162100 27,042 -722 -2.60 8,449 7.04 1.0739
2024-04-16 2024-03-31 13F AMGEN COM 031162100 27,764 -322 -1.15 7,894 -2.42 0.9880
2024-01-26 2023-12-31 13F AMGEN COM 031162100 28,086 592 2.15 8,089 9.47 1.0971
2023-10-12 2023-09-30 13F AMGEN COM 031162100 27,494 -239 -0.86 7,389 20.01 1.1253
2023-07-24 2023-06-30 13F AMGEN COM 031162100 27,733 -729 -2.56 6,157 -10.51 0.8906
2023-04-24 2023-03-31 13F AMGEN COM 031162100 28,462 -304 -1.06 6,881 -8.93 1.0731
2023-01-24 2022-12-31 13F AMGEN COM 031162100 28,766 818 2.93 7,555 19.92 1.2255
2022-10-14 2022-09-30 13F AMGEN COM 031162100 27,948 954 3.53 6,300 -4.08 1.1403
2022-07-25 2022-06-30 13F AMGEN COM 031162100 26,994 3,067 12.82 6,568 13.52 1.1444
2022-04-26 2022-03-31 13F AMGEN COM 031162100 23,927 1,760 7.94 5,786 16.02 0.8645
2022-01-31 2021-12-31 13F AMGEN COM 031162100 22,167 -4,607 -17.21 4,987 -12.42 0.6798
2021-10-20 2021-09-30 13F AMGEN COM 031162100 26,774 -997 -3.59 5,694 -15.88 0.8650
2021-07-26 2021-06-30 13F AMGEN COM 031162100 27,771 446 1.63 6,769 -0.44 1.0338
2021-04-20 2021-03-31 13F AMGEN COM 031162100 27,325 344 1.27 6,799 9.61 1.0850
2021-01-25 2020-12-31 13F AMGEN COM 031162100 26,981 -329 -1.20 6,203 -10.63 1.0632
2020-10-16 2020-09-30 13F AMGEN COM 031162100 27,310 1,369 5.28 6,941 13.43 1.3329
2020-07-14 2020-06-30 13F AMGEN COM 031162100 25,941 3,980 18.12 6,119 37.44 1.3251
2020-04-20 2020-03-31 13F AMGEN COM 031162100 21,961 455 2.12 4,452 -14.12 1.2856
2020-01-27 2019-12-31 13F AMGEN COM 031162100 21,506 4,828 28.95 5,184 60.64 1.0513
2019-10-15 2019-09-30 13F AMGEN COM 031162100 16,678 3,168 23.45 3,227 29.60 0.7069
2019-07-17 2019-06-30 13F AMGEN COM 031162100 13,510 526 4.05 2,490 0.93 0.5570
2019-04-15 2019-03-31 13F AMGEN COM 031162100 12,984 -132 -1.01 2,467 -3.37 0.5776
2019-01-22 2018-12-31 13F AMGEN COM 031162100 13,116 -532 -3.90 2,553 -9.76 0.6981
2018-10-15 2018-09-30 13F AMGEN COM 031162100 13,648 -136 -0.99 2,829 11.20 0.6278
2018-07-23 2018-06-30 13F AMGEN COM 031162100 13,784 207 1.52 2,544 9.89 0.5965
2018-04-25 2018-03-31 13F AMGEN COM 031162100 13,577 -293 -2.11 2,315 -4.02 0.5629
2018-02-06 2017-12-31 13F AMGEN COM 031162100 13,870 267 1.96 2,412 -4.89 0.5714
2017-10-11 2017-09-30 13F Amgen COM 031162100 13,603 1,277 10.36 2,536 19.45 0.6402
2017-07-05 2017-06-30 13F Amgen COM 031162100 12,326 1,383 12.64 2,123 18.27 0.5544
2017-04-03 2017-03-31 13F Amgen COM 031162100 10,943 1,615 17.31 1,795 31.60 0.4768
2017-01-03 2016-12-31 13F Amgen COM 031162100 9,328 202 2.21 1,364 -10.38 0.3918
2016-10-13 2016-09-30 13F Amgen COM 031162100 9,126 1,882 25.98 1,522 38.11 0.4467
2016-07-01 2016-06-30 13F Amgen COM 031162100 7,244 5,469 308.11 1,102 314.29 0.3361
2016-04-07 2016-03-31 13F Amgen COM 031162100 1,775 1,775 266 0.0870
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.